Activins and activin receptors in cell growth

Proceedings of the Society for Experimental Biology and Medicine

Volumn 214, Issue 2, 1997, Pages 114-122

  Ying, Shao Yao ^a   Zhang, Zhong ^a   Furst, Benjamin ^a   Batres, Yasir ^a   Huang, Guo ^a   Li, Guangwu ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; ACTIVIN RECEPTOR; FOLLISTATIN; INHIBIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; EMBRYO DEVELOPMENT; GROWTH REGULATION; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN LOCALIZATION; RECEPTOR BINDING; SHORT SURVEY;

EID: 0031040196     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-214-44077     Document Type: Short Survey

References (115)

1. Ying S-Y. Inhibins, activins, and follistatin: Gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev 9:267-293, 1988.
2. Ying S-Y. Inhibins and activins: Chemical properties and biological activity. Proc Soc Exp Biol Med 186:253-264, 1987.
3. Hotten G, Neidhardt H, Schneider C, Pohl J. Cloning of a new member of the TGF-β family: A putative new activin βC chain. Biochem Biophys Res Commun 206:608-613, 1995.
4. Oda S, Nishimatsu S-I, Murakami K, Ueno N. Molecular cloning and functional analysis of a new activin β subunit: A dorsal mesoderm-inducing activity in Xenopus. Biochem Biophys Res Commun 210: 581-588, 1995.
5. Ying S-Y, Becker A, Swanson G, Tan P, Ling N, Esch F, Ueno N, Shimasaki S, Guillemin R. Follistatin specifically inhibits pituitary follicle stimulating hormone release in vitro. Biochem Biophys Res Commun 149:133-139, 1987.
6. Shimonaka M, Inouye S, Shimasaki S, Ling N. Follistatin binds to both activin and inhibin through the common beta-subunit. Endocrinology 128:3313-3315, 1991.
7. Vaughan JM, Vale WW. α2-Macroglobulin is a binding protein of inhibin and activin. Endocrinology 132:2038-2050, 1993.
8. Mathews LS. Activin receptors and cellular signaling by the receptor serine kinase family. Endocr Rev 15:310-325, 1994.
9. Attisano L, Wrana JL, Massague J. Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/ threonine kinase receptors. Cell 68:97-108, 1992.
10. Mathews LS, Vale WW, Kintner CR. Cloning of a second type of activin receptor and functional characterization in Xenopus embryos. Science 225:1702-1705, 1992.
11. Stewart AG, Milborrow HM, Ring JM, Crowther CE, Forage RG. Human inhibin genes: Genomic characterisation and sequencing. FEBS Lett 206:329-332, 1986.
12. Mason AJ, Berkemeier LM, Schmelzer CH, Schwall RH. Activin B: Precursor sequences genomic structure and in vitro activities. Mol Endocrinol 3:1352-1358, 1989.
13. Thompson DA, Cronin CN, Martin F. Genomic cloning and sequence analyses of the bovine α-, βA- and βB-inhibin/activin genes. FEBS Lett 226:751-763, 1994.
14. Su AGJ, Hsueh AJW. Characterization of mouse inhibin a gene and its promoter. Biochem Biophys Rev Commun 186:293-300, 1992.
15. Feng Z-M, Li Y-P, Chen C-LC. Analysis of the 5′-flanking regions of rat inhibin α- and β-subunit genes suggests two different regulatory mechanisms. Mol Endocrinol 3:1914-1925, 1989.
16. Shimasaki S, Koga M, Esch F, Cooksey K, Mercado M, Koba A, Ueno N, Ying S-Y, Ling N, Gullemin R. Primary structure of the human follistatin precursor and its genomic organization. Proc Natl Acad Sci USA 85:4218-1222, 1988.
17. Miyanaga K, Shimasaki S. Structural and functional characterization of the rat follistatin (activin-binding protein) gene promoter. Mol Cell Endocrinol 92:99-109, 1993.
18. Barton DE, Yang-Feng TL, Mason AJ, Seeburg PH, Francke U. Mapping of genes for inhibin subunits α, βA, and βB on human and mouse chromosomes and studies of jsd mice. Genomics 5:91-99, 1989.
19. Ansari HA, Pearch PD, Maher DW, Malcolm AA, Wood NJ, Phua SH, Broad TE. Regional mapping of loci from human chromosome 2q to sheep chromosome 2q. Genomics 20:122-124, 1994.
20. Brunner RM, Goldammer T, Hiendleder S, Jager C, Schwerin M. Mapping of the gene encoding for inhibin-beta A (INHBA) to chromosome 4q26 in sheep. Mamm Genome 6:308-309, 1995.
21. Sise JA, Tou HM, Montgomery GW. A TaqI polymorphism at the ovine alpha-inhibin Locus. Anim Genet 22:195, 1991.
22. Tisdall DJ, Penty JM. A PstI restriction fragment polymorphism at the ovine locus for follistatin. Anim Genet 22:437, 1991.
23. Hiendleder S, Leyhe B, Jaeger C, Wassmuth R. A TaqI polymorphism at the ovine beta A-inhibin (INHBA). Anim Genet 23:291, 1993.
24. Pang Z, Pardinas JR, Dermody J, Ozer HL. Dinucleotide repeat polymorphism in the INHBA gene. Hum Mol Genet 2:1982, 1993.
25. Chenevix-Trench G, Southall M, Healey S, Stewart A. BamHI RFLP of the inhibin beta B (INHBB) chain gene on chromosome 2. Nucleic Acids Rev 18:7469, 1990.
26. Betteridge A, Craven RP. A two-site enzyme-linked immunosorbent assay for inhibin. Biol Reprod 45:748-754, 1991.
27. Knight PG, Groome N, Beard AJ. Development of a two-site immunoradiometric assay for dimeric inhibin using antibodies against chemically synthesized fragments of the α and β subunit. J Endocrinol 129:R9-R12, 1991.
28. Groome N. Ultrasensitive two-site assays for inhibin-A and activin-A using monoclonal antibodies raised to synthetic peptides. J Immunol Methods 145:65-69, 1991.
29. Demura R, Suzuki T, Tajima S, Mitsuhashi S, Odagiri E, Eto Y, Sugino H, Demura H. Competitive protein binding assay for activin A/EDF using follistatin determination of activin levels in human plasma. Biochem Biophys Res Commun 185:1148-1154, 1992.
30. Krummen LA, Moore A, Woodruff TK, Covello R, Taylor R, Working P, Mather JP. Localization of inhibin and activin binding sites in the testis during development by in situ ligand binding. Biol Reprod 50:734-744, 1994.
31. Matzuk MM, Finegold MJ, Su J, Hsueh AJW, Bradley A. α-Inhibin is a tumor-suppressor gene with gonadal specificity in mice. Nature 360:313-319, 1992.
32. Gonzalez-Manchon C, Vale W. Activin A, inhibin and transforming growth factor-β modulate growth of two gonadal cell lines. Endocrinology 125:1666-1672, 1989.
33. Vale W, Hsueh AJW, Rivier C, Yu J. The inhibin/activin family of hormones and growth factor. In: Sporn MA, Roberts AB, Eds. Handbook of Experimental Pharmacology. New York: Springer-Verlag, Vol 95:pp211-248, 1990.
34. Shikone T, Matzuk M, Perlas E, Finegold M, Lewis K, Vale W, Bradley A, Hsueh A. Characterization of gonadal sex cord-stromal tumor cell line from inhibin-α and p53-deficient mice: The role of activin as an autocrine growth factor. Mol Endocrinol 8:983-995, 1994.
35. Matzuk MM, Finegold MJ, Mather JP, Krummen L, Lu H, Bradley A. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci USA 91:8817-8821, 1994.
36. Scully RE. Sex cord-stromal tumors. In: Blaustein A, Ed. Pathology of the Female Genital Tract (2nd ed). New York: Springer, pp581-601, 1982.
37. Mather J, Attie K, Woodruff T, Rice G, Phillips D. Activin stimulates spermatogonial proliferation in Germ-Sertoli cell cocultures from immature rat testis. Endocrinology 127:3206-3214, 1990.
38. Lee W, Schwall R, Mason AJ, Mather JP. Interstitial cells secrete an activity with characteristics of the inhibin β-β homodimer, activin. In: Cooke BA, Sharpe RM, Eds. The Molecular and Cellular Endocrinology of the Testis. New York: Serono Symp Raven Press, Vol 50:pp21-27, 1988.
39. Lee W, Mason AJ, Schwall R, Szonyi E, Mather JP. Secretion of activin by interstitial cells in the testis. Science 243:396-398, 1989.
40. Hancock AD, Robertson DM, de Kretser DM. Inhibition and inhibin alpha-chain precursors are produced by immature rat Sertoli cells in culture. Biol Reprod 46:155-161, 1992.
41. Roberts V, Meunier H, Sawchenko PE, Vale W. Differential production and regulation of inhibin subunits in rat testicular cell types. Endocrinology 125:2350-2359, 1989.
42. Shaha C, Morris PL, Chen CL, Vale W, Bardin CW. Immunostainable inhibin subunits are in multiple types of testicular cells. Endocrinology 125:1941-1950, 1989.
43. Bhasin S, Krummen LA, Swerdloff RS, Morelos BS, Kim WH, di-Zerega GS, Ling N, Esch F, Shimaski S, Toppari J. Stage dependent expression of inhibin alpha and beta-B subunits during the cycle of the rat seminiferous epithelium. Endocrinology 124:987-991, 1989.
44. Hsueh AJW, Dahl KD, Vaughan J, Tucker E, Rivier J, Bardin CW, Vale WW. Heterodimers and homodimers of inhibin subunits have different paracrine action in the modulation of lutenizing hormone-stimulated androgen biosynthesis. Proc Natl Acad Sci USA 84:5082-5086, 1987.
45. Lin T, Calkins H, Morris PL, Vale WW, Bardin CW. Regulation of Leydig cell function in primary cultures by inhibin and activin. Endocrinology 125:2134-2140, 1989.
46. Drummond AE, Risbridger GP, de Kretser DM. The involvement of Leydig cells in the regulation of inhibin secretion by the testis. Endocrinology 125:510-515, 1989.
47. Sharpe RM, Kerr JB, Maddocks S. Evidence for a role of the Leydig cell in control of the intratesticular secretion of inhibin. Mol Cell Endocrinol 60:243-247, 1988.
48. van Dissel-Emiliani FM, Grootenhuis AJ, de Jong FH, de Rooij DG. Inhibin reduces spermatogonial numbers in testes of adult mice and Chinese hamsters. Endocrinology 15:1899-1903, 1989.
49. Feng ZM, Madigan MB, Chen CL. Expression of type II activin receptor genes in the male and female reproductive tissues of the rat. Endocrinology 1322:2593-2600, 1993.
50. Antti K, Toppari J, Huhtaniemi I, Paranko J. Sex difference in the action of activin-A on cell proliferation of differentiating rat gonad. Endocrinology 134:2165-2170, 1994.
51. Roberts VJ, Barth SL. Expression of messenger ribonucleic acids encoding the inhibin/activin system during mid- and late-gestation rat embryogenesis. Endocrinology 134:914-923, 1994.
52. OW-S, Robertson D, de Kretser DM. Inhibin as an oocyte meiotic inhibitor. Mol Cell Endocrinol 62:307-311, 1989.
53. 4 pituitary tumor cell proliferation. Endocrinology 128:1981-1990, 1991.
54. Bilezikjian LM, Blount AL, Campen CA, Gonzalez-Manchon C, Vale W. Activin-A inhibits proopiomelanocortin messenger RNA accumulation and adrenocorticotropin secretion of AtT20 cells. Mol Endocrinol 5:1389-1395, 1991.
55. Billestrup N, Gonzalez-Manchon C, Potter E, Vale W. Inhibition of somatotroph growth and growth hormone biosynthesis by activin in vitro. Mol Endocrinol 4:356-362, 1990.
56. Katayama T, Shiota K, Takashi M. Effects of activin A on anterior pituitary cells fractionated by centrifugal elutriation. Mol Cell Endocrinol 77:167-173, 1991.
57. Katayama T, Shiota K, Takashi M. Activin A increases the number of follicle-stimulating hormone cells in anterior pituitary cultures. Mol Cell Endocrinol 69:179-185, 1990.
58. Cameron VA, Nishimura E, Mathews LS, Lewis KA, Sawchenko PE, Vale WW. Hybridization histochemical localization of activin receptor subtypes in rat brain, pituitary, ovary, and testis. Endocrinology 134:799-808, 1994.
59. Spencer SJ, Rabinovici J, Jaffe RB. Human recombinant activin-A inhibits proliferation in human fetal adrenal cells in vitro. J Clin Endocrinol Metab 71:1678-1680, 1990.
60. de Kretser DM, Foulds LM, Hancock M, Robertson DM. Partial characterization of inhibin, activin, and follistatin in the term human placenta. J Clin Endocrinol Metab 79:502-507, 1994.
61. Yasuda H, Tanaka S, Ohnishi H, Mashima H, Ogushi N, Mine T, Kojima I. Activin A: Negative regulator of amylase secretion and cell proliferation in rat pancreatic acinar AR42J cells. Am J Physiol 267:G220-G226, 1994.
62. Kotajima A, Miyamoto Y, Tsuruo M, Kosaka M, Saito S. Effects of activin A on deoxyribonucleic acid synthesis, iodine metabolism, and cyclic adenosine monophosphate accumulation in porcine thyroid cells. Endocrinology 136:1414-1418, 1995.
63. Tuuri T, Eramaa M, Hilden K, Ritvos O. The tissue distribution of activin βA- and βB-subunit and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development. J Clin Endocrinol Metab 78:1521-1524, 1994.
64. Inoue S, Orimo A, Hosoi T, Matsuse T, Hashimoto M, Yamada R, Ouchi Y, Orimo H, Muramatsu M. Expression of follistatin, an activin-binding protein in vascular smooth muscle cells and arteriosclerotic lesions. Arterioscler Thromb 13:1859-1864, 1993.
65. Ying S-Y, Zhang Z. mRNAs for activin and activin receptors are expressed in fetal bovine heart endothelial cells. Int J Oncol 7:759-763, 1995.
66. BuBois RN. Activin A and hepatocyte growth regulation. Hepatology 19:788-790, 1994.
67. Yasuda H, Mine T, Shibata H, Eto Y, Hasegawa Y, Takeuchi T, Asano S, Kojima I. Activin A: An autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. J Clin Invest 92:1491-1496, 1993.
68. Scwall RH, Robbins K, Jardieu P, Chang L, Lai C, Terrel TG. Activin induces cell death in hepatocytes in vivo and in vitro. Hepatology 18:347-356, 1993.
69. Nishihara T, Okahashi N, Ueda N. Activin A induces apoptotic cell death. Biochem Biophys Res Commun 197:985-991, 1993.
70. Hully JR, Chang L, Schwall RH, Widmer R, Terrel TG, Gillet NA. Induction of apoptosis in the murine liver with recombinant human activin A. Hepatology 20:854-861, 1994.
71. Broxmeyer JE, Lu L, Cooper S, Schwall RH, Mason AJ, Nikolics K. Selective and indirect modulation of human multipotential and erythroid hematopoietic progenitor cell proliferation by recombinant human activin and inhibin. Proc Natl Acad Sci USA 85:9052, 1988.
72. Shao L, Frigon NL Jr., Sehy DW, Yu AL, Lofgren J, Schwall R, Yu J. Regulation of production of activin A in human marrow stromal cells and monocytes. Exp Hematol 20:1235-1242, 1992.
73. Uchimaru K, Motokura T, Takahashi S, Sakurai T, Asano S, Yamashita T. Bone marrow stromal cells produce and respond to activin A: Interactions with basic fibroblast growth factor and platelet-derived growth factor. Exp Hematol 23:613-618, 1995.
74. Sakai R, Eto Y, Ohtsuka M, Hirafuji M, Shinoda H. Activin enhances osteoclast-like cell formation in vitro. Biochem Biophys Res Commun 195:39-46, 1993.
75. Shao L, Frigon NL Jr., Young AL, Yu AL, Mathews LS, Vaughan J, Vale W, Yu J. Effect of activin A on globin gene expression in purified human erythroid progenitors. Blood 79:773-781, 1992.
76. Yu J, Shao L-E, Vaughan J, Vale W, Yu AL. Characterization of the potentiation effect of activin on human erythroid colony formation in vitro. Blood 73:952, 1989.
77. Mizuguchi T, Kosaka M, Saito S. Activin A suppressed proliferation of interleukin-3-responsive granulocyte-macrophage colony-forming progenitors in the peripheral blood. Blood 81:2891-2897, 1993.
78. Chen P, Yu YM, Reddi AH. Chondrogenesis in chick limb bud mesodermal cells: Reciprocal modulation by activin and inhibin. Exp Cell Res 206:119-127, 1993.
79. 78a. Jiang T-X, Yi J-R, Ying S-Y, Chuong C-M. Activin enhances chondrogenesis of limb bud cells: Stimulation of precartilagenous mesenchymal condensations and expression of NCAM. Dev Biol 155:545-557, 1993.
80. Ying S-Y, Becker A. Inhibin and activin modulate transforming growth factor-β-induced immunosuppression. J Biomed Sci 2:237-241, 1995.
81. Hashimoto M, Kondo S, Sakurai T, Etoh Y, Shibai H, Muramatsu M. Activin/EDF as an inhibitor of neural differentiation. Biochem Biophys Res Commun 173:193-220, 1990.
82. Nishihara T, Ohsaki Y, Ueda N, Koseki T, Eto Y. Induction of apoptosis in B lineage cells by activin A derived from macrophages. J Interferon Cytokine Res 15:509-516, 1995.
83. Jaffee GJ, Harrison CE, Lui GM, Roberts WL, Goldsmith PC, Mesiano S, Jaffee RB. Activin expression by cultured human retinal pigment epithelial cells. Invest Opthalmol Vis Sci 35:2924-2931, 1994.
84. Eto Y, Tsuji T, Takezawa M, Takano S, Yokogawa Y, Shibai H. Purification and characterization of erythroid differentiation factor (EDF) isolated from human leukemia cell line THP-1. Biochem Biophys Res Commun 142:1095-1103, 1987.
85. Murata M, Eto Y, Shibai H, Sakai M, Murumatsu M. Erythroid differentiation factor is encoded by the same mRNA as that of the inhibin beta A chain. Proc Natl Acad Sci USA 85:2434-2438, 1988.
86. Mashima H, Kanzaki M, Nobusawa R, Zhang YQ, Suzuki M, Mine T, Kojima I. Derangements in the activin-follistatin system in hepatoma cell. Gastroenterology 108:834-840, 1995.
87. Xu J, McKeehan K, Matsuzaki K, McKeehan WL. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism. J Biol Chem 270:6308-6313, 1995.
88. Zhang Z, Batres Y, Ying S-Y. Activin A inhibits growth and hexamethylene bisacetamide-induced differentiation in human retinoblastoma Y-79 cells. Anticancer Res 16:269-272, 1996.
89. Batres Y, Zhang Z, Ying S-Y. Expression of activin and activin receptors messenger RNAs in LNCaP cells, a human prostatic adenocarcinoma cell line. Int J Oncol 6:1185-1188, 1995.
90. Furst B, Zhang Z, Ying S-Y. Expression of activin and activin receptors in human prostatic carcinoma cell line DUI45. Int J Oncol 7:239-243, 1995.
91. Ying S-Y, Zhang Z, Xing W. Expression of activin and activin receptors in PC3 human prostatic cancer cells. Int J Oncol 6:601-606, 1995.
92. Ying S-Y, Zhang Z, Huang G, Hsieh F-C. Inhibin/activin subunits and activin receptors in human breast cell lines and lactating rat mammary glands. Int J Oncol 7:481-485, 1995.
93. Ying S-Y, Zhang Z, Huang G, Batres Y. Activin and activin receptors in a rat osteogenic sarcoma line, UMR-106. Int J Oncol 7:1061-1065, 1995.
94. Jones EA, Woodland HR. The development of animal cap cells in Xenopus: A measure of the start of a cap competence to form mesoderm. Development 101:557-563, 1987.
95. Nieuwkoop PD. The formation of mesoderm in urodelean amphibians. I. Induction by the endoderm. Wilhelm Roux Arch. EntwMech Org 162:341-373, 1969.
96. Dohrmann CE, Hemmati-Brivanlou A, Thomsen GH, Fields A, Woolf TM, Melton DA. Expression of activin mRNA during early development in Xenopus laevis. Dev Biol 157:474-483, 1993.
97. Hemmati-Brinvanlou A, Wright DA, Melton DA. Embryonic expression and functional analysis of a Xenopus activin receptor. Dev Dyn 194:1-11, 1992.
98. Fukui A, Nakamura T, Uchiyama H, Sugino K, Sugino H, Asashima M. Identification of activins A, AB, and B and follistatin proteins in Xenopus laevis. Dev Biol 163:279-281, 1994.
99. Tashiro K, Yamada R, Asano M, Hashimoto M, Murumatsu M, Shiokawa K. Expression of mRNA for activin-binding protein (follistatin) during early embryonic development of Xenopus laevis. Biochem Biophys Res Commun 174:1022-1027, 1991.
100. Matzuk MM, Lu N, Vogel H, Sellheyer K, Roop DR, Bradley A. Multiple defects and perinatal death in mice deficient in follistatin. Nature 374:360-363, 1995.
101. Tuuri T, Erämaa M, Hildén K, Ritvos O. The tissue distribution of activin βA- and βB-subunit and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development. J Clin Endocrinol Metab 78:1521-1524, 1994.
102. Albano RM, Groome N, Smith JC. Activins are expressed in preimplantation mouse embryos and in ES and EC cells and are regulated on their differentiation. Development 117:711-723, 1993.
103. Albano RM, Arkell R, Beddington RSP, Smith JC. Expression of inhibin subunits and follistatin during postimplantation mouse development: decidual expression of activin and expression of follistatin in primitive streak, somites and hindbrain. Development 120:803-813, 1994.
104. Roberts VJ, Sawchenko PE, Vale W. Expression of inhibin/activin subunit messenger ribonucleic acids during rat embryogenesis. Endocrinology 128:3122-3129, 1991.
105. Voultilainen R, Erämaa M, Ritvos O. Hormonally regulated inhibin gene expression in human fetal and adult adrenals. J Clin Endocrinol Metab 73:1026-1030, 1991.
106. Tuuri T, Eramaa M, Hilden K, Ritvos O. The tissue distribution of activin beta A- and beta B-subunit and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development. J Clin Endocrinol Metab 78:1521-1524, 1994.
107. Erämaa M, Heikinheimo K, Voultilainen R. Developmental and cyclic adenosine 3′, 5′ monophosphate-dependent regulation of inhibin subunit messenger ribonucleic acids in human fetal testes. J Clin Endocrinol Metab 75:806-811, 1992.
108. Hildén K, Tuuri T, Erämaa M, Ritvos O. Expression of type II activin receptor genes during differentiation of human K562 cells and cDNA cloning of the human type IIB activin receptor. Blood 83:2163-2170, 1994.
109. Matzuk MM, Kumar TR, Vassalli A, Bickenbauch JR, Roop DR, Jaenisch R, Bradley A. Functional analysis of activins during mammalian development. Nature 374:354-356, 1995.
110. Vassalli A, Matzuk MM, Gardner HA, Lee KF, Jaenisch R. Activin/ Inhibin βB-subunit gene disruption leads to defects in eyelid development and female reproduction. Genes Dev 8:414-427, 1994.
111. Matzuk MM, Kumar TR, Bradley A. Different phenotypes for mice deficient in either activins or activin receptor type II. Nature 374:356-360, 1995.
112. Michel U, Farnworth P, Findlay JK. Follistatins: More than follicle-stimulating hormone suppressing proteins. Mol Cell Endocrinol 91:1-11, 1993.
113. Nakamura T, Takio K, Eto Y, Shibai H, Titani K, Sugino H. Activin-binding protein from rat ovary is follistatin. Science 264:836-838, 1990.
114. Hemmati-Brivanlou A, Kelly OG, Melton DA. Follistatin, an antagonist of activin, is expressed in the Spemann organizer and displays direct neutralizing activity. Cell 77:1022-1027, 1991.
115. Smith J. Angles on activin's absence. Science 374:311-312, 1995.